WO2008075320A3 - Antilipidemic pharmaceutical compositions and process for preparation thereof - Google Patents

Antilipidemic pharmaceutical compositions and process for preparation thereof Download PDF

Info

Publication number
WO2008075320A3
WO2008075320A3 PCT/IB2007/055298 IB2007055298W WO2008075320A3 WO 2008075320 A3 WO2008075320 A3 WO 2008075320A3 IB 2007055298 W IB2007055298 W IB 2007055298W WO 2008075320 A3 WO2008075320 A3 WO 2008075320A3
Authority
WO
WIPO (PCT)
Prior art keywords
preparation
pharmaceutical compositions
antilipidemic
antilipidemic pharmaceutical
twice
Prior art date
Application number
PCT/IB2007/055298
Other languages
French (fr)
Other versions
WO2008075320A2 (en
Inventor
Sumit Madan
Ravinder Singh
Puneet Tyagi
Vinod Kumar Arora
Original Assignee
Ranbaxy Lab Ltd
Sumit Madan
Ravinder Singh
Puneet Tyagi
Vinod Kumar Arora
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd, Sumit Madan, Ravinder Singh, Puneet Tyagi, Vinod Kumar Arora filed Critical Ranbaxy Lab Ltd
Publication of WO2008075320A2 publication Critical patent/WO2008075320A2/en
Publication of WO2008075320A3 publication Critical patent/WO2008075320A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release

Abstract

The present invention relates to a new process for preparing an oral pharmaceutical composition comprising fenofibrate alone or in combination with at least one other antilipidemic agent in a single dosage form that can be conveniently administered once or twice in a day.
PCT/IB2007/055298 2006-12-21 2007-12-21 Antilipidemic pharmaceutical compositions and process for preparation thereof WO2008075320A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN2752DE2006 2006-12-21
IN2752/DEL/2006 2006-12-21
IN2353/DEL/2007 2007-11-12
IN2353DE2007 2007-11-12

Publications (2)

Publication Number Publication Date
WO2008075320A2 WO2008075320A2 (en) 2008-06-26
WO2008075320A3 true WO2008075320A3 (en) 2008-08-14

Family

ID=39325048

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2007/055298 WO2008075320A2 (en) 2006-12-21 2007-12-21 Antilipidemic pharmaceutical compositions and process for preparation thereof

Country Status (1)

Country Link
WO (1) WO2008075320A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200904341A2 (en) * 2009-06-03 2010-12-21 Bi̇lgi̇ç Mahmut Stable pharmaceutical compositions containing rosuvastatin calcium.
EA201270269A1 (en) * 2009-08-13 2012-09-28 Синтон Б.В. PHARMACEUTICAL TABLET CONTAINING ROSUVASTATIN CALCIUM
US8722083B2 (en) * 2012-06-25 2014-05-13 Mylan, Inc. Fenofibrate formulation
US9439860B2 (en) 2012-06-25 2016-09-13 Mylan, Inc. Fenofibrate formulation
US20160303102A1 (en) * 2013-12-05 2016-10-20 Alrise Biosystems Gmbh Process for the production of drug formulations for oral administration
WO2016198113A1 (en) 2015-06-11 2016-12-15 Alrise Biosystems Gmbh Process for the preparation of drug loaded microparticles
JP2022542004A (en) 2019-07-31 2022-09-29 インタス ファーマシューティカルズ リミテッド Pharmaceutical composition containing HMG-CoA reductase inhibitor and fenofibrate
CN114831951B (en) * 2022-04-25 2023-10-03 扬子江药业集团广州海瑞药业有限公司 Ezetimibe tablet and preparation method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3152519C2 (en) * 1980-11-19 1990-11-22 Claude Laruelle New fenofibrate ready-to-use product with delayed release of active ingredient
WO2004028506A1 (en) * 2002-09-24 2004-04-08 Ranbaxy Laboratories Limited Oral pharmaceutical compositions of fenofibrate having high bioavailability
WO2006037344A1 (en) * 2004-10-01 2006-04-13 Lifecycle Pharma A/S Pharmaceutical compositions comprising fenofibrate and atorvastatin

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3152519C2 (en) * 1980-11-19 1990-11-22 Claude Laruelle New fenofibrate ready-to-use product with delayed release of active ingredient
WO2004028506A1 (en) * 2002-09-24 2004-04-08 Ranbaxy Laboratories Limited Oral pharmaceutical compositions of fenofibrate having high bioavailability
WO2006037344A1 (en) * 2004-10-01 2006-04-13 Lifecycle Pharma A/S Pharmaceutical compositions comprising fenofibrate and atorvastatin

Also Published As

Publication number Publication date
WO2008075320A2 (en) 2008-06-26

Similar Documents

Publication Publication Date Title
WO2008075320A3 (en) Antilipidemic pharmaceutical compositions and process for preparation thereof
IL234166B (en) Isoindoline compounds, pharmaceutical compositions comprising the same and use thereof in the preparation of medicaments
IL193762A (en) Compounds useful in inhibiting dgat1-related disorders, pharmaceutical compositions comprising them and use thereof in preparation of medicaments
IL210452A (en) Derivatives of dimethyl-oxo-dihydro-(pyridine-3 or 4-yl)- phenyl- 6- methyl-6 - phenyl -[1,3]- oxazine -2- one, pharmaceutical compositions comprising them and their use in the manufacture of medicaments
IL195732A (en) Pharmaceutical compositions comprising fesoterodine, use thereof and method for its preparation
IL184758A0 (en) New pharmaceutical compositions useful in the transmucosal administration of drugs
WO2010066749A3 (en) Ulipristal acetate tablets
IL206952A (en) Aminodihydrothiazine derivatives, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments
IL196775A (en) 2,4-bis(3-methyl-morpholin-4-yl)-7-phenyl-pyrido[2,3-d]pyrimidine derivatives, pharmaceutical compositions comprising them and use thereof as medicaments and in the manufacture of medicaments
IL199362A (en) Pyridopyrimidine compounds, pharmaceutical compositions comprising them, the compounds for use as medicaments and use of the compounds in the manufacture of medicaments
IL194699A (en) Tetrahydropteridines, compositions comprising them and use thereof in the preparation of medicaments
TW200621317A (en) Pharmaceutical composition
UA93709C2 (en) 12-imidazolyl-1-dodecanol and use thereof in the preparation of pharmaceutical compositions
IL208355A (en) 3,7-dihydropurine-2,6-dione derivatives, processes for their preparation, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments
IL192670A (en) 1,3-dioxane carboxylic acids, process for their preparation, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments
RS52867B (en) Combination therapy with glatiramer acetate and rasagiline for the treatment of multiple sclerosis
WO2007112272A3 (en) Formulations of low dose diclofenac and beta-cyclodextrin
ZA200810124B (en) Pharmaceutical combination comprising 3-(3-dimethyl-amino-1-ethyl-2-methyl-propyl)-phenol and Paracetamol
WO2007138466A3 (en) Pharmaceutical compositions comprising meloxicam and tramadol combination
IL201730A (en) Derivatives of 1h-benzoimidazol-2-yl-propyl-methyl-amino-ethyl-5-aryl-bicyclo[2.2.2]oct-5-en-2-ol, pharmaceutical compositions comprising them and their use in the manufacture of medicaments
IL203936A (en) Derivatives of 4-pyrimidinesulfamide, process for their preparation, pharmaceutical compositions comprising them and their use in the manufacture of medicaments
EP2015740A4 (en) Novel low dose pharmaceutical compositions comprising nimesulide, preparation and use thereof
WO2008113901A3 (en) Composition with controlled release of levetiracetam and method for preparing same
HRP20151091T1 (en) USE OF 24-norUDCA
WO2009068708A8 (en) Pharmaceutical composition with prolonged release of somatostatin or an analogue thereof

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200780047730.5

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07859516

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07859516

Country of ref document: EP

Kind code of ref document: A2